A phase 2 trial shows that a single dose of psilocybin provides lasting relief from symptoms of depression and anxiety. New results from a clinical trial show that a single dose of psilocybin, a naturally occurring psychedelic compound found in mushrooms, can lead to lasting reductions in depression and anxiety in people with cancer who [...]from SciTechDaily https://ift.tt/bv5T9zU
